A compact analyzer simultaneously provides a complete blood count (CBC) and C-reactive protein (CRP) from just 18 μL of blood in only 4 minutes. After a highly successful release in Japan, the instrument is now available in Europe.

Horiba Medical (Kyoto, Japan), specialists in automated in vitro diagnostic systems for hematology and chemistry analysis, launched the Microsemi CRP hematology analyzer.

The Microsemi CRP provides information of great clinical value enabling quicker and more accurate medical decisions to ultimately reduce hospitalization times and patient costs. Its powerful CRP analysis allows the screening of patient samples to detect the presence of inflammation caused by bacterial infections, or other treatable inflammatory disease.

Measurement is possible immediately after blood sample collection, making this analyzer the ideal choice for emergency testing. The Microsemi CRP can also be used to assess infection and inflammatory conditions that require progressive observation. In addition, its microsampling capabilities are ideal for pediatric blood analysis, requiring only 10µL for CBC and 18 µL for CBC+CRP, and can be used with capillary, as well as venous blood samples.

Comprehensive and efficient on-board software, color touch screen, alongside fast and easy access to results, adds to the Microsemi CRP’s success. Design features have created an environmentally friendly model (using a noncyanide reagent for hemoglobin measurement) that is compact, lightweight, and quiet. The Microsemi CRP does not require specialized staff.

According to Cleve Wright, UK general manager, Horiba Medical, “With over 2000 instruments successfully being used in Japan to date, UK clinicians can now benefit from the Microsemi CRP’s accuracy, convenience, and ability to support early and rapid diagnosis of patients.”

Related Links:
Horiba Medical